Indeed, several studies have observed that schwannomas in patients with germline SMARCB1 PVs exhibit a mosaic SMARCB1 protein expression pattern as determined by immunohistochemistry [28, 363, 366, 367]. Here, SMARCB1 is linked to schwannoma.